Therapeutics Company Launches Trial For Advanced Cancer Treatment

Monopar Therapeutics Begins Groundbreaking Phase 1 Trial of MNPR-101-Zr Radiopharmaceutical for Advanced Cancers.

Disclaimer: This post includes affiliate links. If you purchase anything through these affiliated links, the author/website may earn a commission.

Monopar Therapeutics Inc. (MNPR) has received clearance to commence its highly anticipated Phase 1 dosimetry clinical trial of the novel radiopharmaceutical, MNPR-101-Zr. This marks a significant milestone in …